Cited by 713Hormonal and reproductive studiesProstate Cancer Treatment and ResearchMenopause: Health Impacts and Treatments

The DOI matches its Crossref record; 78 of the 78 references it cites were found in a registry or an index.

Risks of testosterone-replacement therapy and recommendations for monitoring.

Rhoden, Ernani Luis, Morgentaler, Abraham·2004·New England Journal of Medicine

DOI 10.1056/nejmra022251

Open this paper in CoChat — free account

Abstract

Although some reports suggest that testosterone-replacement therapy may provide benefits for aging men, considerable controversy remains regarding indications for its use. Neither large-scale nor long-term studies have been initiated, in part because of theoretical concern regarding the risks associated with testosterone therapy, especially the possible stimulation of prostate cancer. This article discusses what is known (and not known) about the risks of testosterone-replacement therapy and provides recommendations for monitoring men who are receiving testosterone.

Integrity signals

Registry

Crossref · 10.1056/nejmra022251

Cites

78 of 78 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Risks and Benefits of Estrogen Plus Progestin in Healthy Postmenopausal Women: Principal Results From the Women's Health Initiative Randomized Controlled Trial
Writing Group for the Women's Health Initiative Investigators (2002) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.288.3.321 · Cited by 15,889
Longitudinal Effects of Aging on Serum Total and Free Testosterone Levels in Healthy Men
Harman, S. M., Metter, E. J., Tobin, J. D., Pearson, J., & Blackman, M. R. (2001) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.86.2.7219 · Cited by 2,760
Estrogen plus Progestin and the Risk of Coronary Heart Disease
Manson, J. E., Hsia, J., Johnson, K. C., Rossouw, J. E., Assaf, A. R., Lasser, N. L., Trevisan, M., Black, H. R., Heckbert, S. R., Detrano, R., et al. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa030808 · Cited by 2,065
STUDIES ON PROSTATIC CANCER
Huggins, C. (1941) · Archives of Surgery · doi:10.1001/archsurg.1941.01210140043004 · Cited by 1,694
Longitudinal Evaluation of Prostate-Specific Antigen Levels in Men With and Without Prostate Disease
Carter, H. B. (1992) · JAMA · doi:10.1001/jama.1992.03480160073037 · Cited by 1,076
Testosterone Replacement in Older Hypogonadal Men: A 12-Month Randomized Controlled Trial
Sih, R., Morley, J. E., Kaiser, F. E., Perry, H. M., Patrick, P., & Ross, C. (1997) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.82.6.3988 · Cited by 920
Longitudinal changes in testosterone, luteinizing hormone, and follicle-stimulating hormone in healthy older men
Morley, J. E., Kaiser, F. E., Perry, H. M., Patrick, P., Morley, P. M. K., Stauber, P. M., Vellas, B., Baumgartner, R. N., & Garry, P. J. (1997) · Metabolism · doi:10.1016/s0026-0495(97)90057-3 · Cited by 830
Prospective Study of Sex Hormone Levels and Risk of Prostate Cancer
Gann, P. H., Hennekens, C. H., Ma, J., Longcope, C., & Stampfer, M. J. (1996) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/88.16.1118 · Cited by 782
The Frequency of Carcinoma and Intraepithelial Neoplasia of the Prostate in Young Male Patients
Sakr, W., Haas, G. P., Cassin, B. F., Pontes, J. E., & Crissman, J. D. (1993) · The Journal of Urology · doi:10.1016/s0022-5347(17)35487-3 · Cited by 744
Studies on prostatic cancer: I. The effect of castration, of estrogen and of androgen injection on serum phosphatases in metastatic carcinoma of the prostate. 1941.
Huggins, C., & Hodges, C. (2002) · Journal of Urology · doi:10.1016/s0022-5347(02)80307-x · Cited by 637
Effects of Testosterone Replacement in Hypogonadal Men1
Snyder, P. J., Peachey, H., Berlin, J. A., Hannoush, P., Haddad, G., Dlewati, A., Santanna, J., Loh, L., Lenrow, D. A., Holmes, J. H., et al. (2000) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.85.8.6731 · Cited by 610
Low-Dose Transdermal Testosterone Therapy Improves Angina Threshold in Men With Chronic Stable Angina: A Randomized, Double-Blind, Placebo-Controlled Study
English, K. M., Steeds, R. P., Jones, T. H., Diver, M. J., & Channer, K. S. (2000) · Circulation · doi:10.1161/01.cir.102.16.1906 · Cited by 582
Low Levels of Endogenous Androgens Increase the Risk of Atherosclerosis in Elderly Men: The Rotterdam Study
Hak, A. E., Witteman, J. C. M., de Jong, F. H., Geerlings, M. I., Albert Hofman, D., & Pols, H. A. P. (2002) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.87.8.3632 · Cited by 482
Effects of Testosterone Replacement in Hypogonadal Men
Snyder, P. J. (2000) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.85.8.2670 · Cited by 464
Androgens in Men — Uses and Abuses
Bagatell, C. J., & Bremner, W. J. (1996) · New England Journal of Medicine · doi:10.1056/nejm199603143341107 · Cited by 463
Effect of Testosterone Treatment on Bone Mineral Density in Men Over 65 Years of Age
Snyder, P. J. (1999) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.84.6.1966 · Cited by 460
Effects of transdermal testosterone on bone and muscle in older men with low bioavailable testosterone levels
Kenny, A. M., Prestwood, K. M., Gruman, C. A., Marcello, K. M., & Raisz, L. G. (2001) · The Journals of Gerontology Series A: Biological Sciences and Medical Sciences · doi:10.1093/gerona/56.5.m266 · Cited by 456
Effects of Testosterone on Coronary Vasomotor Regulation in Men With Coronary Heart Disease
Webb, C. M., McNeill, J. G., Hayward, C. S., de Zeigler, D., & Collins, P. (1999) · Circulation · doi:10.1161/01.cir.100.16.1690 · Cited by 451
Testosterone supplementation improves spatial and verbal memory in healthy older men
Cherrier, M. M., Asthana, S., Plymate, S. R., Baker, L. D., Matsumoto, A. M., Peskind, E. R., Raskind, M. A., Brodkin, K. I., Bremner, W., Petrova, A., et al. (2001) · Neurology · doi:10.1212/wnl.57.1.80 · Cited by 450
Longitudinal assessment of serum free testosterone concentration predicts memory performance and cognitive status in elderly men.
Moffat, S., Zonderman, A., Metter, E., Blackman, M. R., Harman, S., & Resnick, S. (2002) · Journal of Clinical Endocrinology and Metabolism · doi:10.1210/jc.2002-020419 · Cited by 426
Pharmacokinetics, Efficacy, and Safety of a Permeation-Enhanced Testosterone Transdermal System in Comparison with Bi-Weekly Injections of Testosterone Enanthate for the Treatment of Hypogonadal Men
Dobs, A. S. (1999) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.84.10.3469 · Cited by 381
Longitudinal Relation between Endogenous Testosterone and Cardiovascular Disease Risk Factors in Middle-aged Men: A 13-Year Follow-up of Former Multiple Risk Factor Intervention Trial Participants
Zmuda, J. M., Cauley, J. A., Kriska, A. M., Glynn, N. W., Gutai, J. P., & Kuller, L. H. (1997) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a009326 · Cited by 362
Transdermal Testosterone Gel Improves Sexual Function, Mood, Muscle Strength, and Body Composition Parameters in Hypogonadal Men
Wang, C. (2000) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.85.8.2839 · Cited by 359
Men with coronary artery disease have lower levels of androgens than men with normal coronary angiograms
English, K. (2000) · European Heart Journal · doi:10.1053/euhj.1999.1873 · Cited by 350
Outcomes of Long-Term Testosterone Replacement in Older Hypogonadal Males: A Retrospective Analysis
Hajjar, R. R., Kaiser, F. E., & Morley, J. E. (1997) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.82.11.4387 · Cited by 324
Effect of Verification Bias on Screening for Prostate Cancer by Measurement of Prostate-Specific Antigen
Punglia, R. S., D'Amico, A. V., Catàlona, W. J., Roehl, K. A., & Kuntz, K. M. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa021659 · Cited by 324
IS LOW SERUM FREE TESTOSTERONE A MARKER FOR HIGH GRADE PROSTATE CANCER?
Hoffman, M. A., DeWolf, W. C., & Morgentaler, A. (2000) · The Journal of Urology · doi:10.1016/s0022-5347(05)67812-3 · Cited by 318
Longitudinal evaluation of prostate-specific antigen levels in men with and without prostate disease
Carter, H. B. (1992) · JAMA · doi:10.1001/jama.267.16.2215 · Cited by 305
Occult Prostate Cancer in Men With Low Serum Testosterone Levels
Morgentaler, A. (1996) · JAMA · doi:10.1001/jama.1996.03540230054035 · Cited by 272
TESTOSTERONE REPLACEMENT IN HYPOGONADAL MEN: EFFECTS ON OBSTRUCTIVE SLEEP APNOEA, RESPIRATORY DRIVES, AND SLEEP
Matsumoto, A. M., Sandblom, R. E., Schoene, R. B., Lee, K. A., Giblin, E. C., Pierson, D. J., & Bremner, W. J. (1985) · Clinical Endocrinology · doi:10.1111/j.1365-2265.1985.tb00161.x · Cited by 246
Intramuscular testosterone esters and plasma lipids in hypogonadal men: a meta-analysis
Whitsel, E. A., Boyko, E. J., Matsumoto, A. M., Anawalt, B. D., & Siscovick, D. S. (2001) · The American Journal of Medicine · doi:10.1016/s0002-9343(01)00833-6 · Cited by 240
LIVER DAMAGE FROM LONG-TERM METHYLTESTOSTERONE
Westaby, D., Paradinas, F. J., OGLE, S. J., Randell, J., & Murray-Lyon, I. M. (1977) · The Lancet · doi:10.1016/s0140-6736(77)90949-7 · Cited by 238
Androgen Replacement Therapy in the Aging Male--A Critical Evaluation
Vermeulen, A. (2001) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.86.6.7630 · Cited by 226
The Effects of Varying Doses of T on Insulin Sensitivity, Plasma Lipids, Apolipoproteins, and C-Reactive Protein in Healthy Young Men
Singh, A. B., Hsia, S. H., Alaupovic, P., Sinha‐Hikim, I., Woodhouse, L. J., Buchanan, T. A., Shen, R., Bross, R., Berman, N., & Bhasin, S. (2002) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.87.1.8172 · Cited by 225
DIGITAL RECTAL EXAMINATION FOR DETECTING PROSTATE CANCER AT PROSTATE SPECIFIC ANTIGEN LEVELS OF 4 NG./ML. OR LESS
Carvalhal, G. F., Smith, D. S., MAGER, D. E., Ramos, C. G., & Catàlona, W. J. (1999) · The Journal of Urology · doi:10.1016/s0022-5347(01)61785-3 · Cited by 224
Managing the Risks of Prostate Disease During Testosterone Replacement Therapy in Older Men: Recommendations for a Standardized Monitoring Plan
Bhasin, S., Singh, A. B., Mac, R. P., Carter, B., Lee, M. I., & Cunningham, G. R. (2003) · Journal of Andrology · doi:10.1002/j.1939-4640.2003.tb02676.x · Cited by 219
Hormones and Prostate Cancer: What's Next?
Hsing, A. W. (2001) · Epidemiologic Reviews · doi:10.1093/oxfordjournals.epirev.a000795 · Cited by 211
Effect of aging on endogenous level of 5 alpha-dihydrotestosterone, testosterone, estradiol, and estrone in epithelium and stroma of normal and hyperplastic human prostate
Krieg, M., Nass, R. M., & Tunn, S. (1993) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.77.2.7688377 · Cited by 185
Influence of testosterone on breathing during sleep
Schneider, B. K., Pickett, C. K., Zwillich, C. W., Weil, J. V., McDermott, M. T., Santen, R. J., Varano, L. A., & White, D. P. (1986) · Journal of Applied Physiology · doi:10.1152/jappl.1986.61.2.618 · Cited by 179
INFLUENCE OF RADICAL PROSTATECTOMY ON SERUM HORMONE LEVELS
MILLER, L. R., Partin, A. W., Chan, D. W., Bruzek, D. J., Dobs, A. S., Epstein, J. I., & Walsh, P. C. (1998) · The Journal of Urology · doi:10.1016/s0022-5347(01)62922-7 · Cited by 178
Emerging Issues in Androgen Replacement Therapy
Bhasin, S., & Bremner, W. J. (1997) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.82.1.3640 · Cited by 178
A novel testosterone gel formulation normalizes androgen levels in hypogonadal men, with improvements in body composition and sexual function
McNicholas, T. A., Dean, J. D., Mulder, H., Carnegie, C., & Jones, N. A. (2003) · BJU International · doi:10.1046/j.1464-410x.2003.04016.x · Cited by 178
Prostate-specific antigen cutoff of 2.6 ng/mL for prostate cancer screening is associated with favorable pathologic tumor features
KRUMHOLTZ, J. S., Carvalhal, G. F., Ramos, C. G., Smith, D. S., Thorson, P. K., Yan, Y., Humphrey, P. A., Roehl, K. A., & Catàlona, W. J. (2002) · Urology · doi:10.1016/s0090-4295(02)01875-7 · Cited by 169
Prostate-specific antigen variability in men without prostate cancer: effect of sampling interval on prostate-specific antigen velocity
Carter, H. B., Chan, D. W., Pearson, J. D., Guess, H. A., Waclawiw, Z., Walsh, P. C., & Metter, E. J. (1995) · Urology · doi:10.1016/s0090-4295(99)80049-1 · Cited by 152
Treatment of Male Hypogonadism With Testosterone Undecanoate Injected at Extended Intervals of 12 Weeks: A Phase II Study
von Eckardstein, S., & Nieschlag, E. (2002) · Journal of Andrology · doi:10.1002/j.1939-4640.2002.tb02249.x · Cited by 144
Longitudinal evaluation of serum androgen levels in men with and without prostate cancer
Carter, H. B., Pearson, J. D., Metter, E. J., Chan, D. W., Andres, R., Fozard, J. L., Rosner, W., & Walsh, P. C. (1995) · The Prostate · doi:10.1002/pros.2990270106 · Cited by 141
The Effects of Transdermal Dihydrotestosterone in the Aging Male: A Prospective, Randomized, Double Blind Study
Kunelius, P., Lukkarinen, O. A., Hannuksela, M. L., Itkonen, O., & Tapanainen, J. S. (2002) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.87.4.8138 · Cited by 141
Testosterone Supplementation in Older Men: A Rational Idea Whose Time Has Not Yet Come
Bhasin, S., & Buckwalter, J. G. (2001) · Journal of Andrology · doi:10.1002/j.1939-4640.2001.tb02570.x · Cited by 136
Serum testosterone and sex hormone-binding globulin concentrations and the risk of prostate carcinoma: a longitudinal study.
Heikkilä, R., Aho, K., Heliövaara, M., Hakama, M., Marniemi, J., Reunanen, A., & Knekt, P. (1999) · PubMed · Cited by 134
Effect of transdermal testosterone treatment on serum lipid and apolipoprotein levels in men more than 65 years of age
Snyder, P. J., Peachey, H., Berlin, J. A., Rader, D. J., Usher, D. C., Loh, L., Hannoush, P., Dlewati, A., Holmes, J. H., Santanna, J., et al. (2001) · The American Journal of Medicine · doi:10.1016/s0002-9343(01)00813-0 · Cited by 116
MALE HORMONE REPLACEMENT THERAPY INCLUDING “ANDROPAUSE”
Tenover, J. L. (1998) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/s0889-8529(05)70050-5 · Cited by 114
Testosterone
Slater, S., & Oliver, R. T. D. (2000) · Drugs & Aging · doi:10.2165/00002512-200017060-00001 · Cited by 98
Haemostatic Effects of Supraphysiological Levels of Testosterone in Normal Men
Anderson, R. A., Ludlam, C. A., & Wu, F. C. W. (1995) · Thrombosis and Haemostasis · doi:10.1055/s-0038-1649799 · Cited by 95
Cardiovascular risk factors in men: The role of gonadal steroids and sex hormone-binding globulin
Gyllenborg, J., Rasmussen, S. L., Borch‐Johnsen, K., Heitmann, B. L., K, N. E. S., & Juul, A. (2001) · Metabolism · doi:10.1053/meta.2001.24916 · Cited by 95
Emerging Issues in Androgen Replacement Therapy
Bhasin, S. (1997) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.82.1.3 · Cited by 95
Hormonal Signaling in Prostatic Hyperplasia and Neoplasia*
Marcelli, M., & Cunningham, G. R. (1999) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.84.10.6083 · Cited by 90
Risks Versus Benefits of Testosterone Therapy in Elderly Men
Basaria, S. S., & Dobs, A. S. (1999) · Drugs & Aging · doi:10.2165/00002512-199915020-00006 · Cited by 90
Testosterone and risk factors for cardiovascular disease in men.
Barrett-Connor, E. L. (1995) · PubMed · Cited by 89
Dramatic rise in prostate-specific antigen after androgen replacement in a hypogonadal man with occult adenocarcinoma of the prostate
Curran, M. J., & Bihrle, W. (1999) · Urology · doi:10.1016/s0090-4295(98)00348-3 · Cited by 87
Effect of aging on endogenous level of 5 alpha-dihydrotestosterone, testosterone, estradiol, and estrone in epithelium and stroma of normal and hyperplastic human prostate
Krieg, M. (1993) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.77.2.375 · Cited by 87
The age‐related decline of androgen levels in men: clinically significant?
Gooren, L. J. (1996) · British Journal of Urology · doi:10.1046/j.1464-410x.1996.05918.x · Cited by 81
Multiple hepatic adenomas after long-term therapy with testosterone enanthate
Carrasco, D., Prieto, M., Pallardó, L., Moll, J., Cruz, J. M., Muñoz, C., & Berenguer, J. (1985) · Journal of Hepatology · doi:10.1016/s0168-8278(85)80001-5 · Cited by 76
Andropause: Hormone Replacement Therapy in the Ageing Male
Comhaire, F. H. (2000) · European Urology · doi:10.1159/000020358 · Cited by 68
Occult prostate cancer in men with low serum testosterone levels
Morgentaler, A. (1996) · JAMA · doi:10.1001/jama.276.23.1904 · Cited by 62
Self-citation
Impact of radical prostatectomy and TURP on the hypothalamic-pituitary-gonadal hormone axis
Stephan Madersbacher, A., Schatzl, G., Bieglmayer, C., REITER, W. J., Gassner, C., Berger, P., Zidek, T., & Marberger, M. (2002) · Urology · doi:10.1016/s0090-4295(02)01893-9 · Cited by 57
Prostate Cancer after Exogenous Testosterone Treatment for Impotence
Loughlin, K. R., & Richie, J. P. (1997) · The Journal of Urology · doi:10.1016/s0022-5347(01)64881-x · Cited by 53
Hormonal Signaling in Prostatic Hyperplasia and Neoplasia
Marcelli, M. (1999) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.84.10.3463 · Cited by 51
Androgen administration in middle‐aged and ageing men: effects of oral testosterone undecanoate on dihydrotestosterone, oestradiol and prostate volume
Pechersky, A., Vi, M., Семиглазов, В. Ф., Karpischenko, A., Vv, M., & Udintsev, A. V. (2002) · International Journal of Andrology · doi:10.1046/j.1365-2605.2002.00335.x · Cited by 50
Relationship between Endogenous Sex Hormone Levels, Lipoproteins and Coronary Atherosclerosis in Men Undergoing Coronary Angiography
Kabakçı, G., Yı́ldı́rı́r, A., Can, İ., Ünsal, İ., & Erbaş, B. (1999) · Cardiology · doi:10.1159/000006977 · Cited by 46
Testosterone supplementation in the aging male
Kim, Y. C. (1999) · International Journal of Impotence Research · doi:10.1038/sj.ijir.3900446 · Cited by 44
Dihydrotestosterone and testosterone levels in men screened for prostate cancer: a study of a randomized population
Gustafsson, O., Norming, U., Gustafsson, S. A., Eneroth, P. H. E., Åström, G., & Nyman, C. R. (1996) · British Journal of Urology · doi:10.1046/j.1464-410x.1996.89120.x · Cited by 44
Exaggerated levothyroxine malabsorption due to calcium carbonate supplementation in gastrointestinal disorders
Csako, G., McGriff, N. J., Rotman-Pikielny, P., Sarlis, N. J., & Pucino, F. (2001) · Annals of Pharmacotherapy · doi:10.1345/aph.1a031 · Cited by 40
The development of new brain tumor therapy utilizing the local and sustained delivery of chemotherapeutic agents from biodegradable polymers
Brem, H., & Lawson, H. C. (1999) · Cancer · doi:10.1002/(sici)1097-0142(19990715)86:2 · Cited by 38
Polycythaemia as a complication of transdermal testosterone therapy
Viallard, J., Marit, G., Mercié, P., Leng, B., Reiffers, J. J., & Pellegrin, J. (2000) · British Journal of Haematology · doi:10.1046/j.1365-2141.2000.02072-3.x · Cited by 36
Changes in Lipoprotein-Lipid Levels in Normal Men Following Administration of Increasing Doses of Testosterone Cypionate
Kouri, E. M., Pope, H. G., & Oliva, P. S. (1996) · Clinical Journal of Sport Medicine · doi:10.1097/00042752-199607000-00003 · Cited by 31
Verification Bias and the Prostate-Specific Antigen Test — Is There a Case for a Lower Threshold for Biopsy?
Schröder, F. H., & Kranse, R. (2003) · New England Journal of Medicine · doi:10.1056/nejme030073 · Cited by 30
VII. If Testosterone, Which Testosterone? Which Androgen Regimen Should be Used for Supplementation in Older Men? Formulation, Dosing, and Monitoring Issues
Nieschlag, E. (1998) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.83.10.5060-7 · Cited by 18
Summary from the Second Annual Andropause Consensus Meeting
(2004) · CRC Press eBooks · doi:10.1201/b13940-9 · Cited by 18

Research works printed but not linked: 11

10.1210/jc.86.2.724 · DOI · Paper page
10.1210/jc.82.6.1661 · DOI
10.1210/jc.83.10.3443 · DOI
10.1210/jc.82.11.3793 · DOI
10.1210/jc.87.1.136 · DOI
10.1210/jc.87.4.1467 · DOI
Barrett-Connor EL, 1995, Diabetes Metab, 21, 156
2002, Endocr Rep, 2, 1
10.1210/jc.86.6.2380 · DOI
Westaby D, 1977, Lancet, 2, 262
10.1345/aph.1A020 · DOI · Paper page

Sorted by citations

Molecular and Cellular Basis of Cardiovascular Gender Differences
Mendelsohn, M. E., & Karas, R. H. (2005) · Science · doi:10.1126/science.1112062 · Cited by 1,105
The Decline of Androgen Levels in Elderly Men and Its Clinical and Therapeutic Implications
Kaufman, J. M., & Vermeulen, A. (2005) · Endocrine Reviews · doi:10.1210/er.2004-0013 · Cited by 1,079
Investigation, treatment and monitoring of late-onset hypogonadism in males
Wang, C., Nieschlag, E., Swerdloff, R., Behre, H. M., Hellstrom, W. J., Gooren, L. J., Kaufman, J. M., Legros, J.-J., Lunenfeld, B., Morales, A., et al. (2008) · European Journal of Endocrinology · doi:10.1530/eje-08-0601 · Cited by 867
Endogenous Testosterone and Mortality Due to All Causes, Cardiovascular Disease, and Cancer in Men: European Prospective Investigation Into Cancer in Norfolk (EPIC-Norfolk) Prospective Population Study
Khaw, K.-T., Dowsett, M., Folkerd, E., Bingham, S., Wareham, N., Luben, R., Welch, A., & Day, N. (2007) · Circulation · doi:10.1161/circulationaha.107.719005 · Cited by 743
Effect of Testosterone Supplementation on Functional Mobility, Cognition, and Other Parameters in Older Men: A Randomized Controlled Trial
Emmelot-Vonk, M. H., Verhaar, H. J. J., Nakhai Pour, H. R., Aleman, A., Lock, T. M. T. W., Bosch, J. L. H. R., Grobbee, D. E., & van der Schouw, Y. T. (2008) · JAMA · doi:10.1001/jama.2007.51 · Cited by 518
“A stimulatory effect of testosterone on erythropoiesis has been documented in several studies.(73) This effect was confirmed in our study, but without apparent clinical consequences.”

See all 713

Authors: Rhoden, E. L., & Morgentaler, A.
Affiliations: Beth Israel Deaconess Medical Center (US)
ORCID: Morgentaler, Abraham
Venue: New England Journal of Medicine
Publisher: Massachusetts Medical Society
Published: 2004-01-29
Volume: 350
Issue: 5
Pages: 482-492
ISSN: 0028-4793 (ISSN-L)
1533-4406
DOI: 10.1056/nejmra022251
OpenAlex: W2120158027
Cited by: 705
References: 77
Citations by year: 2026: 5 · 2025: 7 · 2024: 12 · 2023: 10 · 2022: 7 · 2021: 16 · 2020: 18 · 2019: 21 · 2018: 19 · 2017: 20 · 2016: 22 · 2015: 36 · 2014: 30 · 2013: 35 · 2012: 44
FWCI: 9.78
Type: journal article
Language: en
Open access: closed
Locations: New England Journal of Medicine (publishedVersion)
PubMed (publishedVersion)
Topics: Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Hormonal and reproductive studies
Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Prostate Cancer Treatment and Research
Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Menopause: Health Impacts and Treatments
Keywords: testosterone replacement therapy, risk, prostate cancer, older men, monitoring, androgen therapy, hypogonadism
MeSH terms: Cardiovascular Diseases, Humans, Hypogonadism, Lipids, Male, Polycythemia, Prostatic Diseases, Risk Factors, Testosterone, Drug Monitoring, Prostate-Specific Antigen, Age Distribution, Hormone Replacement Therapy

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Risks of testosterone-replacement therapy and recommendations for monitoring.

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks